share_log

Roth MKM Reiterates Buy on Bio-Path Hldgs, Maintains $40 Price Target

Moomoo 24/7 ·  Apr 18 13:57

Roth MKM analyst Philip Shen reiterates Bio-Path Hldgs (NASDAQ:BPTH) with a Buy and maintains $40 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment